SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001005201-19-000054
Filing Date
2019-04-02
Accepted
2019-04-02 09:50:29
Documents
2
Period of Report
2019-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_155421301470982.html 3  
1 FORM 3 wf-form3_155421301470982.xml 3 2266
2 GALEOTA POA a1powerofattorney-galeota.htm EX-24 3252
  Complete submission text file 0001005201-19-000054.txt   7002
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEDICINES CO 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Galeota James JR (Reporting) CIK: 0001721236 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13111 | Film No.: 19723068